BMBF grant “Sleep characteristics, sleep disturbances, and health-related consequences”
For the period August 2014 to July 2017, the CCE works on a research program entitled “sleep characteristics, sleep disturbances, and health-related consequences”
(BMBF grant 01ER1305, sum 1.445.042 €).
more information:

SOEP innovation panel: Sleep
The CCE studies causes of daytime napping and sleep hygiene based on the innovation panel of the Socio-Economic Panel (SOEP).
more information:

National Cohort: Sleep
The CCE plus some other scientists is responsible for the assessment of sleep characteristic in the National Cohort (

The team has developed the sleep assessment for the National Cohort and is responsible for the quality control of the sleep assessment in the National Cohort.
Among others, new algorithms for the analysis of actigraphy data will be developed.
more information:

Testicular cancer research
Dr. Stang has done epidemiologic research on testicular cancer since 1996. Currently, his team is doing a high resolution study on the incidence of germ cell cancers together with the cancer registry of North-Rhine Westphalia.

Epidemiology of Merkel cell carcinoma
The CCE currently conducts a study on the incidence of Merkel cell carcinoma together with Dr. Jürgen Becker  ( and Dr. Jacques Ferlay (

Methodological research on NHST
The CCE conducts projects related to null hypothesis significance testing (NHST) in biomedical research. The projects try to give overviews of the many pitfalls associated with NHST. Furthermore, solutions to get out of the NHST fallacy are promoted by several research acitivites.
more information:

PRODAST: Prospective Record Of the use of Dabigatran in patients with Acute Stroke or TIA
In conjunction with the department of neurology of the university medical centre
(PI: Prof. Diener) and the centre for clincal studies (ZKSE) in Essen the ZKE is involved in planning and evaluation of a german wide observational study that will comprise about 10.000 patients with non-valvular atrial fibrillation hospitalized with acute stroke or TIA. The study evaluates the incidence rates for severe bleeding and recurrent stroke during a 3-months follow-up after discharge with regard to different strategies for secondary prevention.
Special interest is to find the best point in time to start a treatment with a new oral anticoagulant (NOAC).

Epidemiology of renal failure
Available data from studies among patients with renal failure in Germany and Israel will be cross-sectionally analyzed with a special focus on etiopathogenesis and risk factors of renal failure in close collaboration with the foundation “KfH Stiftung Präventivmedizin”. This project will provide important epidemiological data on renal failure in Germany and Israel (Grant: KfH Stiftung Präventivmedizin; 40.520 €; duration: 18 months).